<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05031923</url>
  </required_header>
  <id_info>
    <org_study_id>waiting..</org_study_id>
    <nct_id>NCT05031923</nct_id>
  </id_info>
  <brief_title>Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy</brief_title>
  <official_title>Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kafrelsheikh University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kafrelsheikh University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Antimicrobial photodynamic therapy (aPDT) is characterized by the association of&#xD;
      photosensitizing agents, promoting the generation of reactive oxygen species like free&#xD;
      radicals and singlet oxygen, which are cytotoxic to certain bacteria. Simvastatin (SMV)&#xD;
      enhances alkaline phosphatase activity and increases the expression of bone sialoprotein,&#xD;
      osteocalcin, and type I collagen and is shown to have an anti-inflammatory effect by&#xD;
      decreasing the production of C-reactive protein (CRP), IL-6, and IL-8. SMV is also reported&#xD;
      to stimulate VEGF release in a dose-dependent manner which promotes osteoblast&#xD;
      differentiation and bone nodule formation. The aim of this study is to evaluate the&#xD;
      adjunctive effects of SMV with and without aPDT in chronic periodontitis patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical evaluation and measurements of the defect in millimeters</measure>
    <time_frame>9 months</time_frame>
    <description>Changes in clinical measurements after application of simvastatin with and without antimicrobial photodynamic therapy in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic evaluation and measurements of the defect in millimeters</measure>
    <time_frame>9 months</time_frame>
    <description>Changes in bone formation in millimeters after application of simvastatin with and without antimicrobial photodynamic therapy in millimeters</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Simvastatin</condition>
  <condition>Photodynamic Therapy</condition>
  <condition>Periodontal Diseases</condition>
  <arm_group>
    <arm_group_label>SMV and antimicrobial photodynamic therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application SMV and antimicrobial photodynamic therapy in intrabony defect</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMV application</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application SMV in intrabony defect</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SMV and antimicrobial photodynamic therapy</intervention_name>
    <description>Application of SMV and antimicrobial photodynamic therapy in intrabony defects</description>
    <arm_group_label>SMV and antimicrobial photodynamic therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SMV application</intervention_name>
    <description>Application of SMV without antimicrobial photodynamic therapy in intrabony defects</description>
    <arm_group_label>SMV application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients were all healthy and free from any systemic disease;&#xD;
&#xD;
          -  no history of antibiotic therapy or periodontal treatment for at least 6 months&#xD;
             preceding the study;&#xD;
&#xD;
          -  patients were willing and able to return for multiple follow-up visits;&#xD;
&#xD;
          -  good levels of oral hygiene&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant and lactating female patients,&#xD;
&#xD;
          -  smokers,&#xD;
&#xD;
          -  alcoholics,&#xD;
&#xD;
          -  those receiving any medication that could affect healing of soft or hard tissue&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dalia R Issa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kafrelsheikh University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dalia R Issa, PhD</last_name>
    <phone>01007753636</phone>
    <phone_ext>002</phone_ext>
    <email>dalia_rasheed@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Dentistry, Kafrelsheikh University</name>
      <address>
        <city>Kafr Ash Shaykh</city>
        <zip>33511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Dalia R Issa, PhD</last_name>
      <phone>01007753636</phone>
      <phone_ext>002</phone_ext>
      <email>dalia_rasheed@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 20, 2021</study_first_submitted>
  <study_first_submitted_qc>August 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 2, 2021</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kafrelsheikh University</investigator_affiliation>
    <investigator_full_name>Dalia Rasheed Issa</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

